The primary aim of acquisition is to expand into high-entry barrier and super-specialty segments, particularly in women's health and fertility, where BSV has a strong presence
Read More
The Government of India’s Amrit Kaal blueprint -Vision Pharma 2047 – which envisages India as ‘Vishwaguru’ (global leader) in innovation & research underscores the Government's commitment to nurture an innovation-driven ecosystem
Read More
This research, recently published in Nature Biomedical Engineering, marks a significant step forward in the fight against some of medicine's most challenging diseases
Read More
